Experts zero in on key protein in search for coronavirus treatment

03/13/2013 | Bloomberg Businessweek

A new coronavirus that has infected at least 15 people and killed nine in the past year adheres to the DPP4 cell-surface protein, but diabetes drugs that block the protein aren't effective in stopping the virus, and existing antibodies that block the virus also kill somatic cells, according to new research. It is possible the drugs tested on the virus do not block the portion of the protein where the pathogen adheres, so future research will look more deeply into how the virus attaches. Scientists are also testing a potential vaccine, but it would not be available to humans anytime soon.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA